Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys

Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys

Establishing how many people have been infected by SARS-CoV-2 remains an urgent priority for controlling the COVID-19 pandemic. Serological tests that identify past infection can be used to estimate cumulative incidence, but the relative accuracy and robustness of various sampling strategies have be...

Full description

Bibliographic Details
Main Authors: Daniel B Larremore, Bailey K Fosdick, Kate M Bubar, Sam Zhang, Stephen M Kissler, C Jessica E Metcalf, Caroline O Buckee, Yonatan H Grad
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2021-03-01
Series:eLife
Subjects:
SARS-CoV-2
COVID-19
antibody
serology
modeling
uncertainty
Online Access:https://elifesciences.org/articles/64206

Internet

https://elifesciences.org/articles/64206

Similar Items